Rome, Italy

Antonella Migliorini

This inventor holds 1 USPTO granted patent. Top assignee: Recordati Industria Chimica E Farmaceutica S.p.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonella Migliorini. Retrieved from https://idiyas.com/inventor/antonella-migliorini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonella Migliorini: Pharmaceutical Process Innovation

Introduction

Antonella Migliorini is an inventor associated with Rome, Italy, and Recordati Industria Chimica e Farmaceutica S.p.A. Her patent work concerns the preparation of cysteamine bitartrate and its crystalline forms.

Latest Patents

Migliorini is associated with 1 patent: “Process for the Preparation of Cysteamine Bitartrate and Product So Obtained.” The invention describes an enhanced process for manufacturing cysteamine bitartrate and its key intermediate, thiazolidine. It also covers processes for producing crystalline anhydrous cysteamine bitartrate, identified as polymorph L2, and the monohydrate form, polymorph L1. The patent describes the anhydrous form as having particularly fine particles and a good appearance.

Career Highlights

Her documented patent contribution focuses on pharmaceutical manufacturing processes and the preparation of cysteamine bitartrate in distinct crystalline forms. The work highlights process development and product characteristics relevant to pharmaceutical production.

Collaborations

Migliorini’s listed coworkers include Francesco Yafteh Mihan and Franca Segnalini. Her patent is associated with Recordati Industria Chimica e Farmaceutica S.p.A.

Conclusion

Antonella Migliorini’s patent work centers on improved methods for preparing cysteamine bitartrate, its intermediate, and two crystalline forms.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…